WallStreetZenWallStreetZen

NASDAQ: ACTU
Actuate Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Actuate Therapeutics earnings were N/A for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest ACTU earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$6.0M, down 9.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ACTU reported annual earnings of -$24.7M, with 22.7% growth.

ACTU earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

ACTU Return on Equity

Insufficient data to display

ACTU Return on Assets

Insufficient data to display

Be the first to know when ACTU announces earnings.

ACTU Return on Capital Employed

Current Company
0%
Current Industry
14.3%

ACTU vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ACTUN/AN/AN/AN/A
CDTX-$121.86M-$123.13MN/A-$25.92
MCRB$2.32M-$25.48MN/A-$0.23
ATOS-$26.88M-$26.91MN/A-$0.22
RPTX-$78.08M-$84.05MN/A-$1.99
View Top Biotech Stocks

Actuate Therapeutics Earnings Reports & History FAQ

What were Actuate Therapeutics's earnings last quarter?

Actuate Therapeutics (NASDAQ: ACTU) reported Q3 2024 earnings per share (EPS) of -$0.55, up 87.24% year over year. Total ACTU earnings for the quarter were -$5.97 million. In the same quarter last year, Actuate Therapeutics's earnings per share (EPS) was -$4.31.

If you're new to stock investing, here's how to buy Actuate Therapeutics stock.

Is Actuate Therapeutics profitable or losing money?

As of the last Actuate Therapeutics earnings report, Actuate Therapeutics is currently losing money. Actuate Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was N/A, a N/A decrease year over year.

What was ACTU's earnings growth in the past year?

As of Actuate Therapeutics's earnings date in Q4 2024, Actuate Therapeutics's earnings has grown year over year. ACTU earnings in the past year totalled N/A.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.